Discovery and characterization of anti-cancer peptides from a random peptide library

Pavan Kumar Puvvula1, Anne M Moon1,2,3

  • 1Department of Molecular and Functional Genomics, Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania, United States of America.

Plos One
|February 13, 2024
PubMed

Insights

Researchers discovered novel therapeutic peptides that specifically target and inhibit breast cancer cell growth and survival. These peptides activate apoptosis without harming healthy cells, offering a promising new avenue for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Breast cancer remains a leading cause of mortality worldwide.
  • Targeted therapies are crucial for improving treatment efficacy and reducing side effects.
  • Identifying novel agents that selectively eliminate cancer cells is a significant challenge.

Purpose of the Study:

  • To discover novel peptides with specific targeting capabilities for breast cancer cells.
  • To investigate the mechanism of action of these identified peptides.
  • To demonstrate a new methodology for therapeutic peptide discovery.

Main Methods:

  • A forward genetic screen utilizing a Penetratin-tagged, random 15-mer peptide library.
  • In vitro assays to assess peptide specificity against breast cancer cells versus normal cells.
  • Analysis of apoptotic pathways, cell cycle gene expression, histone modifications, nuclear structure, and RNA-binding proteins.

Main Results:

  • Identification of a novel group of peptides that selectively inhibit breast cancer cell proliferation and survival.
  • Demonstration that these peptides induce apoptosis via the intrinsic pathway.
  • Observed peptide-specific alterations in cell cycle genes, histone marks, nuclear morphology, and RNA-binding proteins.

Conclusions:

  • The study successfully identified novel peptides with high specificity for targeting breast cancer cells.
  • These peptides represent potential new therapeutic agents for breast cancer treatment.
  • The employed screening method provides a viable strategy for discovering new therapeutic peptides.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...